Home › Heart Failure › Ohio › Akron
Heart Failure clinical trials in Akron, OH
4 studies for Heart Failure are looking for participants at sites in and around Akron (within about 30 miles). Open a study to see who can join and how to contact the study team.
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
RecruitingPhase 3
- Research Site, Canton · 21 mi away
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RecruitingPhase 3
- Akron, OH Investigative Site 10081, Akron
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- Aultman Hospital, Canton · 21 mi away
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
RecruitingPhase 3
- FIN-10081, Akron, OH, Akron
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY50 studies
- Boston, MA43 studies
- Dallas, TX43 studies
- Houston, TX36 studies
- Cleveland, OH33 studies
- Chicago, IL32 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- St. Louis, MO26 studies
- Durham, NC26 studies
- Atlanta, GA25 studies
- Kansas City, MO25 studies
Other studies in Akron
- Non-Small Cell Lung Cancer22 studies
- Lung Cancer16 studies
- Cancer (all types)14 studies
- Breast Cancer13 studies
- Prostate Cancer9 studies
- Melanoma8 studies
- Colorectal Cancer8 studies
- Metastatic Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Small Cell Lung Cancer8 studies
- Endometrial Cancer7 studies
- Steatotic Liver Disease7 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.